Rarely Heard
Rarely Heard is about Hunter syndrome, a rare and life-changing genetic condition and is intended for families, patients, and anyone interested in learning about the disease.
This podcast is initiated and funded by Takeda Pharmaceuticals and is intended for an international audience outside the USA and UK. The information shared is for educational purposes and does not constitute clinical recommendations for diagnosing or managing disease. The speakers received honoraria from Takeda for their participation. The views expressed reflect the experience and opinion of the speaker. VV-MEDMAT-45197
Also Available on
Share & Embed
Available episodes
10
Typical release rate
± 80 days
Latest episode
4 years ago
November 8, 2022
Podcast Privacy Information
Anchor (from Spotify)
Stats, Tracking, Dynamic Audio
Stats: This service collects and aggregates basic information about its listenership, like total download numbers and downloads by date or region.
Tracking: This service may track an individual listener's browsing habits across podcasts and websites. This is typically used to measure advertising conversions. Podbay does not collect any Tracking data.
Dynamic Audio: This service may insert dynamic audio (usually for targeted advertising) into episodes on a per-download or per-stream basis. This could be as basic as factoring in the date or the user's overall region, or when used with Tracking, could be based on more personal user data.
All content for Rarely Heard is the property of Takeda Pharmaceuticals and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podbay in any way.